140 related articles for article (PubMed ID: 35060430)
1. The influence of radiation dose on taste impairment in a prospective observational study cohort of oropharyngeal cancer patients.
Stieb S; Engeseth GM; Mohamed ASR; He R; Perez-Martinez I; Rock S; Deshpande TS; Garden AS; Rosenthal DI; Frank SJ; Gunn GB; Fuller CD
Acta Oncol; 2022 Feb; 61(2):146-152. PubMed ID: 35060430
[TBL] [Abstract][Full Text] [Related]
2. Impact of radiation dose on patient-reported acute taste alteration in a prospective observational study cohort in head and neck squamous cell cancer (HNSCC).
Morelli I; Desideri I; Romei A; Scoccimarro E; Caini S; Salvestrini V; Becherini C; Livi L; Bonomo P
Radiol Med; 2023 Dec; 128(12):1571-1579. PubMed ID: 37642816
[TBL] [Abstract][Full Text] [Related]
3. The impact of tongue-deviating and tongue-depressing oral stents on long-term radiation-associated symptoms in oropharyngeal cancer survivors.
Stieb S; Perez-Martinez I; Mohamed ASR; Rock S; Bajaj N; Deshpande TS; Zaid M; Garden AS; Goepfert RP; Cardoso R; Ferrarotto R; Reddy JP; Phan J; Morrison WH; Rosenthal DI; Koay EJ; Frank SJ; Fuller CD; Gunn GB;
Clin Transl Radiat Oncol; 2020 Sep; 24():71-78. PubMed ID: 32642562
[TBL] [Abstract][Full Text] [Related]
4. Long-term patient reported outcomes following radiation therapy for oropharyngeal cancer: cross-sectional assessment of a prospective symptom survey in patients ≥65 years old.
; Eraj SA; Jomaa MK; Rock CD; Mohamed ASR; Smith BD; Smith JB; Browne T; Cooksey LC; Williams B; Temple B; Preston KE; Aymard JM; Gross ND; Weber RS; Hessel AC; Ferrarotto R; Phan J; Sturgis EM; Hanna EY; Frank SJ; Morrison WH; Goepfert RP; Lai SY; Rosenthal DI; Mendoza TR; Cleeland CS; Hutcheson KA; Fuller CD; Garden AS; Gunn GB
Radiat Oncol; 2017 Sep; 12(1):150. PubMed ID: 28888224
[TBL] [Abstract][Full Text] [Related]
5. Intensity Modulated Proton Therapy Versus Intensity Modulated Photon Radiation Therapy for Oropharyngeal Cancer: First Comparative Results of Patient-Reported Outcomes.
Sio TT; Lin HK; Shi Q; Gunn GB; Cleeland CS; Lee JJ; Hernandez M; Blanchard P; Thaker NG; Phan J; Rosenthal DI; Garden AS; Morrison WH; Fuller CD; Mendoza TR; Mohan R; Wang XS; Frank SJ
Int J Radiat Oncol Biol Phys; 2016 Jul; 95(4):1107-14. PubMed ID: 27354125
[TBL] [Abstract][Full Text] [Related]
6. Prospective observational evaluation of radiation-induced late taste impairment kinetics in oropharyngeal cancer patients: Potential for improvement over time?
Stieb S; Mohamed ASR; Deshpande TS; Harp J; Greiner B; Garden AS; Goepfert RP; Cardoso R; Ferrarotto R; Phan J; Reddy JP; Morrison WH; Rosenthal DI; Frank SJ; Fuller CD; Brandon Gunn G;
Clin Transl Radiat Oncol; 2020 May; 22():98-105. PubMed ID: 32373720
[TBL] [Abstract][Full Text] [Related]
7. Development and validation of a contouring guideline for the taste bud bearing tongue mucosa.
Stieb S; Mohamed ASR; He R; Zhu LL; McDonald BA; Wahid K; van Dijk LV; Ventura J; Ahmed S; McCoy L; Deshpande TS; Grant S; Reddy JP; Phan J; Garden AS; Rosenthal DI; Frank SJ; Gunn GB; Fuller CD
Radiother Oncol; 2021 Apr; 157():63-69. PubMed ID: 33217499
[TBL] [Abstract][Full Text] [Related]
8. Sparing bilateral neck level IB in oropharyngeal carcinoma and xerostomia outcomes.
Tam M; Riaz N; Kannarunimit D; Peña AP; Schupak KD; Gelblum DY; Wolden SL; Rao S; Lee NY
Am J Clin Oncol; 2015 Aug; 38(4):343-7. PubMed ID: 26208401
[TBL] [Abstract][Full Text] [Related]
9. Radiation-induced volume changes in parotid and submandibular glands in patients with head and neck cancer receiving postoperative radiotherapy: a longitudinal study.
Wang ZH; Yan C; Zhang ZY; Zhang CP; Hu HS; Kirwan J; Mendenhall WM
Laryngoscope; 2009 Oct; 119(10):1966-74. PubMed ID: 19688858
[TBL] [Abstract][Full Text] [Related]
10. Symptom Burden Associated With Late Lower Cranial Neuropathy in Long-term Oropharyngeal Cancer Survivors.
Aggarwal P; Zaveri JS; Goepfert RP; Shi Q; Du XL; Swartz M; Gunn GB; Lai SY; Fuller CD; Hanna EY; Rosenthal DI; Lewin JS; Piller LB; Hutcheson KA
JAMA Otolaryngol Head Neck Surg; 2018 Nov; 144(11):1066-1076. PubMed ID: 30193299
[TBL] [Abstract][Full Text] [Related]
11. A prospective study of salivary function sparing in patients with head-and-neck cancers receiving intensity-modulated or three-dimensional radiation therapy: initial results.
Chao KS; Deasy JO; Markman J; Haynie J; Perez CA; Purdy JA; Low DA
Int J Radiat Oncol Biol Phys; 2001 Mar; 49(4):907-16. PubMed ID: 11240231
[TBL] [Abstract][Full Text] [Related]
12. Association of Risk Factors With Patient-Reported Voice and Speech Symptoms Among Long-term Survivors of Oropharyngeal Cancer.
Aggarwal P; Hutcheson KA; Garden AS; Mott FE; Goepfert RP; Duvall A; Fuller CD; Lai SY; Gunn GB; Sturgis EM; Hanna EY; Shete S
JAMA Otolaryngol Head Neck Surg; 2021 Jul; 147(7):615-623. PubMed ID: 33956062
[TBL] [Abstract][Full Text] [Related]
13. A phase II study to assess the efficacy of amifostine for submandibular/sublingual salivary sparing during the treatment of head and neck cancer with intensity modulated radiation therapy for parotid salivary sparing.
Rosenthal DI; Chambers MS; Weber RS; Eisbruch A
Semin Oncol; 2004 Dec; 31(6 Suppl 18):25-8. PubMed ID: 15726519
[TBL] [Abstract][Full Text] [Related]
14. Modeling of salivary production recovery after radiotherapy using mixed models: determination of optimal dose constraint for IMRT planning and construction of convenient tools to predict salivary function.
Ortholan C; Chamorey E; Benezery K; Thariat J; Dassonville O; Poissonnet G; Bozec A; Follana P; Peyrade F; Sudaka A; Gerard JP; Bensadoun RJ
Int J Radiat Oncol Biol Phys; 2009 Jan; 73(1):178-86. PubMed ID: 18565687
[TBL] [Abstract][Full Text] [Related]
15. Intensity-modulated radiation therapy in head and neck cancers: The Mallinckrodt experience.
Chao KS; Low DA; Perez CA; Purdy JA
Int J Cancer; 2000 Apr; 90(2):92-103. PubMed ID: 10814959
[TBL] [Abstract][Full Text] [Related]
16. Dosimetric advantages of intensity-modulated proton therapy for oropharyngeal cancer compared with intensity-modulated radiation: A case-matched control analysis.
Holliday EB; Kocak-Uzel E; Feng L; Thaker NG; Blanchard P; Rosenthal DI; Gunn GB; Garden AS; Frank SJ
Med Dosim; 2016; 41(3):189-94. PubMed ID: 27158021
[TBL] [Abstract][Full Text] [Related]
17. Recurrences near base of skull after IMRT for head-and-neck cancer: implications for target delineation in high neck and for parotid gland sparing.
Eisbruch A; Marsh LH; Dawson LA; Bradford CR; Teknos TN; Chepeha DB; Worden FP; Urba S; Lin A; Schipper MJ; Wolf GT
Int J Radiat Oncol Biol Phys; 2004 May; 59(1):28-42. PubMed ID: 15093896
[TBL] [Abstract][Full Text] [Related]
18. Clinical Use of A Priori Knowledge of Organ-At-Risk Sparing During Radiation Therapy Treatment for Oropharyngeal Cancer: Dosimetric and Patient Reported Outcome Improvements.
Fried DV; Das SK; Marks LB; Chera BS
Pract Radiat Oncol; 2022; 12(3):e193-e200. PubMed ID: 34958985
[TBL] [Abstract][Full Text] [Related]
19. Investigations on parotid gland recovery after IMRT in head and neck tumor patients.
Stock M; Dörr W; Stromberger C; Mock U; Koizar S; Pötter R; Georg D
Strahlenther Onkol; 2010 Dec; 186(12):665-71. PubMed ID: 21136030
[TBL] [Abstract][Full Text] [Related]
20. Intensity modulated radiation therapy for oropharyngeal and oral cavity tumors: clinical use and experience.
Claus F; Duthoy W; Boterberg T; De Gersem W; Huys J; Vermeersch H; De Neve W
Oral Oncol; 2002 Sep; 38(6):597-604. PubMed ID: 12167438
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]